In the medicine field today, the prescription of Adderall is part of an ethnical conflict because of how it is used, and its possible side effects. Adderall is a stimulant in the central nervous system that affects chemicals in the brain that is commonly used for treating Attention Deficit Hyper Activity Disorder, also known as ADHD. ADHD currently effects million of children, and even adults in the United States. The benefits of this drug allow clients to stay on task, and concentrate on things that need to be accomplished. It can also help control hyperactivity, impulsive behavior, and most commonly, inattention.
However, in recent years, scientists have seen how many people have been misusing this drug for personal reasons. It is most popular among college students, typically during finals week, because the stimulant gives students an edge in school. To further this ethical conflict, Wesleyan University’s Honor Code Review Committee recently researched Adderall and its usage. They believe... “It is not fair for someone who is able to pay for and get their hands on one of these different amphetamines to do better on an exam. These students give themselves an unfair advantage, just as athletes who you performance enhancing drugs or steroids have an unfair advantage” (Garner, 2010). Students are obtaining these prescription pills to benefit themselves in the classroom, and as an unnatural aid to help get speed work.
Personally, my sister is on Adderall, and I can only see the benefit side effects. She got prescribed because of ADHD, and is now able to better focus in school. However, due to today’s competitive society, I do see how this drug causes an ethical conflict. I believe that if people are prescribed this drug for the appropriate reasons, and take a series of tests to obtain the drug, and then they should be allowed to use it. It becomes an ethical issue, when people are using it for personal reasons, and to only benefit their studies and other personal habits.
http://students.com.miami.edu/netreporting/?page_id=1558
No comments:
Post a Comment